Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2010 1
2011 1
2013 1
2014 1
2015 1
2016 1
2018 2
2019 1
2020 3
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells.
Kakafika MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, Miliotou AN, Pappas IS, Vizirianakis IS, Papadopoulou LC, Tsiftsoglou AS. Kakafika MG, et al. Among authors: papadopoulou lc. Int J Oncol. 2024 Apr;64(4):42. doi: 10.3892/ijo.2024.5630. Epub 2024 Mar 1. Int J Oncol. 2024. PMID: 38426621 Free PMC article.
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency.
Miliotou AN, Foltopoulou PF, Ingendoh-Tsakmakidis A, Tsiftsoglou AS, Vizirianakis IS, Pappas IS, Papadopoulou LC. Miliotou AN, et al. Among authors: papadopoulou lc. Pharmaceutics. 2023 Jan 14;15(1):286. doi: 10.3390/pharmaceutics15010286. Pharmaceutics. 2023. PMID: 36678915 Free PMC article. Review.
PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients' RBCs ex vivo in the frame of Protein Replacement Therapy.
Miliotou AN, Papagiannopoulou D, Vlachaki E, Samiotaki M, Laspa D, Theodoridou S, Tsiftsoglou AS, Papadopoulou LC. Miliotou AN, et al. Among authors: papadopoulou lc. J Biol Res (Thessalon). 2021 Jul 20;28(1):16. doi: 10.1186/s40709-021-00148-3. J Biol Res (Thessalon). 2021. PMID: 34284828 Free PMC article.
In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations.
Kaiafas GC, Papagiannopoulou D, Miliotou ΑN, Tsingotjidou AS, Chalkidou PC, Tsika AC, Spyroulias GA, Tsiftsoglou AS, Papadopoulou LC. Kaiafas GC, et al. Among authors: papadopoulou lc. Mol Genet Metab Rep. 2020 Dec 8;25:100683. doi: 10.1016/j.ymgmr.2020.100683. eCollection 2020 Dec. Mol Genet Metab Rep. 2020. PMID: 33318931 Free PMC article.
In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development.
Miliotou AN, Papadopoulou LC. Miliotou AN, et al. Among authors: papadopoulou lc. Methods Mol Biol. 2020;2086:87-117. doi: 10.1007/978-1-0716-0146-4_7. Methods Mol Biol. 2020. PMID: 31707670
20 results